Division of Neuroscience, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772, USA.
J Pharmacol Exp Ther. 2010 Aug;334(2):556-65. doi: 10.1124/jpet.110.167619. Epub 2010 May 21.
Dopamine (DA) D3 and D2 receptor mechanisms are implicated in cocaine's abuse-related behavioral effects, but the relative contribution of the two receptor subtypes is only partially characterized. This study investigated the role of D3 and D2 subtype mechanisms by determining the degree to which the D3-preferring antagonist PG01037 [N-{4-[4-(2,3-dichlorophenyl)-piperazin- 1-yl]-trans-but-2-enyl}-4-pyridine-2-yl-benzamide HCl] and the D2-preferring antagonist L-741626 [3-[4-(4-chlorophenyl)-4- hydroxypiperidin-1-yl]methyl-1H-indole] attenuated several behavioral effects of cocaine in squirrel monkeys. Quantitative observational studies established doses of each antagonist that did not produce untoward effects, which were used in subsequent comparisons. In addition, the ability of the D3-preferring agonist PD128907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] and the D2-preferring agonist sumanirole [(R)-5,6-dihydro-5-(methylamino)-4H- imidazo[4,5,1-ij]quinolin-2(1H)-one(Z)-2-butenedioate] to reproduce cocaine's discriminative stimulus (DS) and priming effects were compared. In monkeys trained to discriminate cocaine from vehicle, both DA antagonists attenuated and both DA agonists partially reproduced cocaine's DS effects. PG01037 also selectively attenuated the cocaine-like DS effects of PD128907, whereas L-741626 attenuated the cocaine-like DS effects of both agonists. In self-administration studies, L-741626 nonselectively reduced cocaine- and food-maintained responding, whereas PG01037 was ineffective against either reinforcer. In studies involving reinstatement of extinguished cocaine seeking, both antagonists attenuated cocaine-induced reinstatement of responding, and both agonists induced at least partial reinstatement of cocaine seeking. L-741626 also attenuated sumanirole-induced, but not PD128907-induced, reinstatement of responding, whereas PG01037 was ineffective against either DA agonist. The results are consistent with a role for D3 and D2 receptor mechanisms in cocaine's DS effects and cocaine-induced reinstatement of drug seeking, but provide no evidence for a major role of D3 receptors in the direct reinforcing effects of cocaine.
多巴胺 (DA) D3 和 D2 受体机制与可卡因的滥用相关行为效应有关,但这两种受体亚型的相对贡献仅部分得到了描述。本研究通过确定 D3 偏好拮抗剂 PG01037[N-{4-[4-(2,3-二氯苯基)-哌嗪-1-基]-反式-丁-2-烯基}-4-吡啶-2-基-苯甲酰胺盐酸盐]和 D2 偏好拮抗剂 L-741626[3-[4-(4-氯苯基)-4-羟哌啶-1-基]甲基-1H-吲哚]减弱可卡因在松鼠猴中的几种行为效应的程度,研究了 D3 和 D2 亚型机制的作用。定量观察研究确定了每种拮抗剂的剂量,这些剂量不会产生不良影响,随后将这些剂量用于比较。此外,D3 偏好激动剂 PD128907[(R-(+)-反式-3,4a,10b-四氢-4-丙基-2H,5H-[1]苯并吡喃[4,3-b]-1,4-恶嗪-9-醇)]和 D2 偏好激动剂 sumanirole[(R)-5,6-二氢-5-(甲基氨基)-4H-咪唑[4,5,1-ij]喹啉-2(1H)-酮(Z)-2-丁烯二酸盐]重现可卡因辨别刺激 (DS) 和引发效应的能力也进行了比较。在训练用于辨别可卡因与载体的猴子中,两种多巴胺拮抗剂均减弱,两种多巴胺激动剂均部分重现可卡因的 DS 效应。PG01037 还选择性地减弱了 PD128907 的可卡因样 DS 效应,而 L-741626 减弱了两种激动剂的可卡因样 DS 效应。在自我给药研究中,L-741626 非选择性地降低了可卡因和食物维持的反应,而 PG01037 对任何一种强化剂均无效。在涉及可卡因寻求消退后再激发的研究中,两种拮抗剂均减弱了可卡因诱导的反应再激发,两种激动剂均至少部分诱导了可卡因寻求的再激发。L-741626 还减弱了 sumanirole 诱导的但不是 PD128907 诱导的反应再激发,而 PG01037 对两种多巴胺激动剂均无效。结果表明,D3 和 D2 受体机制在可卡因的 DS 效应和可卡因诱导的药物寻求再激发中起作用,但没有证据表明 D3 受体在可卡因的直接强化作用中起主要作用。